Full video transcriptClick to expand
Auto-generated transcript of @primenutrition.pe's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00In the same way, the more you might have to be able to take a look at the new results.
- 0:08The best way to grow images is to make them look better.
- 0:11You can see the most beautiful beautiful and beautiful images of your body.
- 0:15The best way to grow images is to look at the different dimensions of your body.
- 0:19The most beautiful image of the most beautiful image is of the female.
- 0:22The most beautiful image is to make a look for the female.
- 0:25And he knows that in the past he is in his eyes,
- 0:28but of course he is so bad.
- 0:30He can't be as long as he knows.
- 0:31So he has my...
- 0:33...who is at his back,
- 0:35and he knows that this is the sport we always have.
- 0:39So it's a very simple sport.
- 0:41So inside of it,
- 0:42he has the most insignificant HEA family.
- 0:45He is very talented,
- 0:47who takes the role of CPTB
- 0:50and calm him in the face of his name.
- 0:52He is winning by the world's camera.
- 0:54Soreto's
- 1:16Cresimiento, ita la pazo.
@primenutrition.pe's MK-677 growth hormone claims checked
Quick answer
MK-677 (ibutamoren) is an orally active ghrelin receptor agonist that stimulates pituitary GH release and raises IGF-1 levels. It has been studied in clinical trials for growth hormone deficiency and muscle wasting but has never received FDA approval for any indication, making its sale for human use legally and medically unsanctioned. Documented adverse effects in trials include increased fasting glucose, insulin resistance, water retention, and appetite stimulation, which are clinically relevant risks being omitted in this promotional content.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 10 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @primenutrition.pe's MK-677 growth hormone claims checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Ipamorelin, the first selective growth hormone secretagogue
Background source for ipamorelin selectivity and GH-secretagogue mechanism.
PubMed
The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation
Preclinical context that should not be overstated as consumer clinical evidence.
PubMed
GLP-1 receptor agonists versus metformin in PCOS: a systematic review and meta-analysis
Used for PCOS pages comparing metabolic and weight-management approaches.
PubMed
The efficacy and safety of GLP-1 agonists in PCOS women living with obesity
Supports PCOS, obesity, and hormonal-regulation context.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
@primenutrition.pe's MK-677 growth hormone claims checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Helpful context before the funnel
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "@primenutrition.pe's MK-677 growth hormone claims checked" from Prime Nutrition. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: MK-677 (ibutamoren) is an orally active ghrelin receptor agonist that stimulates pituitary GH release and raises IGF-1 levels.
The reason this review is not generic is the source wording and the canonical claim label "peptides vale la pena usar mk677 comenta crecimiento para envi." In this clip, the useful excerpt is: "In the same way, the more you might have to be able to take a look at the new results." That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Ipamorelin, the first selective growth hormone secretagogue (1998), The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation (2001), and Influence of chronic treatment with the growth hormone secretagogue Ipamorelin (2002), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
MK-677 (ibutamoren) is an orally active ghrelin receptor agonist that stimulates pituitary GH release and raises IGF-1 levels.
FormBlends verdict
Peptide social video fact-checks evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- MK-677 (ibutamoren) is an orally active ghrelin receptor agonist that stimulates pituitary GH release and raises IGF-1 levels. It has been studied in clinical trials for growth hormone deficiency and muscle wasting but has never received FDA approval for any indication, making its sale for human use legally and medically unsanctioned. Documented adverse effects in trials include increased fasting glucose, insulin resistance, water retention, and appetite stimulation, which are clinically relevant risks being omitted in this promotional content.
- MK-677 raises GH and IGF-1 in human trials, but it has no FDA-approved indication and was discontinued before receiving one.
- Nass et al. (2008, Annals of Internal Medicine) found MK-677 increased fasting glucose and worsened insulin sensitivity over a 2-year trial, a risk omitted in most influencer content.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- MK-677 raises GH and IGF-1 in human trials, but it has no FDA-approved indication and was discontinued before receiving one.
- Nass et al. (2008, Annals of Internal Medicine) found MK-677 increased fasting glucose and worsened insulin sensitivity over a 2-year trial, a risk omitted in most influencer content.
- MK-677 mimics ghrelin, meaning appetite stimulation and water retention are expected pharmacological effects, not rare side effects.
- People with insulin resistance, pre-diabetes, active or prior cancer, or pituitary disorders face elevated risk from GH secretagogues and should not self-administer based on social media content.
- High-intensity exercise reliably spikes GH acutely (Ho et al., 1988, Journal of Clinical Investigation) with no metabolic downside, making it a first-line option before any compound is considered.
- Selling MK-677 for human consumption via a social media link is legally ambiguous in most jurisdictions because it is not an approved drug or supplement.
- Any legitimate use of GH secretagogues requires baseline labs including fasting glucose, HbA1c, and IGF-1, none of which a PDF protocol can assess or monitor.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @primenutrition.pe actually say?
Honestly, the transcript here is largely unintelligible. The auto-generated captions appear to be a corrupted or mistranslated rendering of what was likely a Spanish-language video about MK-677 and growth hormone. The caption itself, though, is clear enough: the creator is promoting MK-677 as worth using for growth hormone elevation, offering a "protocol PDF" via DM, and linking to a product for sale. The closing phrase "Soreto's Cresimiento, ita la pazo" is a garbled transliteration of something like "sobre el crecimiento" (about growth). So while we cannot quote the spoken content directly, the commercial intent and the central claim are explicit in the post itself.
The framing is a classic TikTok soft-sell: ask a question ("Is MK-677 worth it?"), tease a guide, and drop a purchase link. That structure shapes what claims are likely being made, even if the transcript can't confirm them word for word.
Does the science back the core premise?
MK-677, also known as ibutamoren, does reliably increase growth hormone (GH) and IGF-1. That part is real. The question is whether the effect is beneficial, safe, or appropriate outside of clinical settings. The honest answer is: it depends heavily on context, and the risks are routinely underplayed by influencers.
MK-677 is a ghrelin receptor agonist, not a peptide in the strict sense, that stimulates the pituitary to release GH. Studies do confirm this mechanism. Nass et al. (2008, Annals of Internal Medicine) found that MK-677 increased GH and IGF-1 in older adults over two years, but also found a significant increase in fasting glucose and insulin resistance. Svensson et al. (1998, Journal of Clinical Endocrinology and Metabolism) confirmed the GH-stimulating effect in healthy adults. So the "raises growth hormone" claim? Accurate. But the side effect profile is real and not trivial. Water retention, increased appetite (it mimics ghrelin, the hunger hormone), elevated blood sugar, and potential worsening of insulin sensitivity are documented. For someone with pre-diabetes or metabolic syndrome, this compound could cause measurable harm.
What did they get wrong, or right?
Credit where it is due: MK-677 does raise GH and IGF-1, and that is not snake oil. The underlying mechanism is reasonably well-studied for a compound that has never received FDA approval for any indication. It reached Phase II trials for growth hormone deficiency and muscle wasting before development was discontinued.
What the creator appears to get wrong, based on the promotional framing, is the risk-benefit calculation. Selling a "protocol PDF" implies this is something you can self-administer with the right instructions. It is not. MK-677 has no approved human dose. It has no approved human indication. The FDA has not cleared it for any use. Selling it for human consumption is legally ambiguous at best. More practically, influencers promoting GH secretagogues to general audiences are not screening for the populations most likely to be harmed: people with insulin resistance, active cancers (GH and IGF-1 are mitogenic), sleep apnea, or pituitary disorders. Posting a purchase link alongside a protocol guide, with no medical history intake, is not responsible health content regardless of how well the compound works in a controlled trial.
What should you actually know?
If you are interested in growth hormone support, the evidence base for lifestyle interventions is actually solid and carries none of the legal or metabolic risk. Ho et al. (1988, Journal of Clinical Investigation) established that even a single bout of high-intensity exercise acutely spikes GH. Slow-wave sleep is the largest driver of endogenous GH release, and sleep deprivation measurably blunts it. Intermittent fasting has also shown GH-elevating effects in multiple studies, including Hartman et al. (1992, Journal of Clinical Endocrinology and Metabolism).
If you are working with a licensed clinician who has evaluated your labs and health history, peptide or secretagogue therapy may be a legitimate conversation to have. But "comment 'Crecimiento' and I'll send you a PDF" is not a medical evaluation. It is a lead generation funnel. The compound being promoted may do something real. The context in which it is being promoted is not appropriate for self-directed use. Those are two different things, and conflating them is how people get hurt.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Prime Nutrition · TikTok creator
75.8K views on this video
😱Vale la pena usar MK677? 👉Comenta "Crecimiento" para enviarte una guía PDF con el protocolo de uso adecuado y otras estrategias para aumentar tu hormona de crecimiento de forma natural. 👉Consígue
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about mk-677 raises gh?
MK-677 raises GH and IGF-1 in human trials, but it has no FDA-approved indication and was discontinued before receiving one.
What does the video say about nass et al. (2008, annals of internal medicine) found mk-677?
Nass et al. (2008, Annals of Internal Medicine) found MK-677 increased fasting glucose and worsened insulin sensitivity over a 2-year trial, a risk omitted in most influencer content.
What does the video say about mk-677 mimics ghrelin, meaning appetite stimulation?
MK-677 mimics ghrelin, meaning appetite stimulation and water retention are expected pharmacological effects, not rare side effects.
What does the video say about people with insulin resistance, pre-diabetes, active?
People with insulin resistance, pre-diabetes, active or prior cancer, or pituitary disorders face elevated risk from GH secretagogues and should not self-administer based on social media content.
What does the video say about high-intensity exercise reliably spikes gh acutely (ho et al., 1988,?
High-intensity exercise reliably spikes GH acutely (Ho et al., 1988, Journal of Clinical Investigation) with no metabolic downside, making it a first-line option before any compound is considered.
What does the video say about selling mk-677 for human consumption via a social media link?
Selling MK-677 for human consumption via a social media link is legally ambiguous in most jurisdictions because it is not an approved drug or supplement.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Prime Nutrition, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.